LONDON, ON and HERZLIYA, Israel, Oct. 5, 2026 /PRNewswire/ -- EpiSign Inc. and Geneyx Genomex Ltd. today announced a partnership to advance the integration of genomic and epigenomic analysis for rare-disease interpretation.The collaboration combines EpiSign's expertise in DNA methylation episignature analysis with Geneyx's genomic and multi-omics capabilities. EpiSign METRIC is available to Geneyx customers, allowing laboratories to...
MELBOURNE, Australia and BASEL, Switzerland, Oct. 5, 2026 /PRNewswire/ -- CSL and Alentis Therapeutics today announced they have entered into an exclusive global collaboration agreement to co-develop and co-promote lixudebart, which has the potential to become a first-in-class therapy targeting claudin-1 across a range of kidney, liver and other diseases.Lixudebart is currently being evaluated in the ongoing Phase 2 RENAL trial in patients...
MILAN, Oct. 4, 2026 /PRNewswire/ -- At the European Association for the Study of Diabetes (EASD) 2026, SiBionics presented "See More, Act Earlier," connecting continuous sensing with future diabetes care. Three exhibition chapters shaped this vision: "See More: Beyond Glucose," covering glucose, ketone and combined monitoring; "Act Earlier: From Insight to Intervention," exploring multimodal sensing and insulin delivery; and "Go Further:...
BEIJING, Sept. 30, 2026 /PRNewswire/ -- Zhendong Pharmaceutical announced that results from a multicenter, randomized, double-blind, placebo-controlled Phase IIb study evaluating its investigational Live Double Combined Lactobacillus Capsule for Vaginal Use for the treatment of bacterial vaginosis (BV) were published in the National Medical Journal of China. The eight-center study randomized 66 patients in an approximately 2:1 ratio to the...
MELBOURNE, Australia, Sept. 28, 2026 /PRNewswire/ -- Heidi, the AI Care Partner for leading clinicians and health systems globally, today unveiled Heidi II, a new version of its platform that acts on the administrative work surrounding every patient visit rather than documenting the visit alone.
HONG KONG, Sept. 28, 2026 /PRNewswire/ -- Recently, spatial omics has become a powerful tool, enabling researchers to see not only what molecules are present in a tissue, but also where they are located and how they are organised across cells, tissue structures and local microenvironments. This spatial context has significantly deepened our understanding of cancer, neurobiology and immunology. Yet as the field keeps advancing, an important...
SINGAPORE, Sept. 25, 2026 /PRNewswire/ -- Gene Solutions, a global biotechnology company providing precision cell-free DNA solutions through multi-omics and artificial intelligence to improve pregnancy care, cancer detection and precision medicine, today announced the publication of a study showing the potential to assess the risk of spontaneous preterm birth from cell-free DNA fragmentomic signals already present in routine first-trimester...
LONDON and BOSTON, Sept. 23, 2026 /PRNewswire/ -- Basecamp Research, a frontier AI company developing AI-designed medicines, today announced a $140M Series C financing to train a new generation of EDEN models and advance a pipeline of AI-designed therapeutics towards clinical development.Basecamp's ambition is to develop cures for diseases that remain incurable by designing medicines that reprogram the body to repair itself. The company...
HONG KONG, Sept. 23, 2026 /PRNewswire/ -- HKSH Medical Group (HKSH) and United Imaging Healthcare (United Imaging) announced on September 23 the arrival of Hong Kong's first long-axial PET/CT, the uMI Panorama GS, at HKSH Cancer Centre, providing a new technology platform for molecular imaging clinical applications and research in Hong Kong. As one of Hong Kong's leading private hospitals, HKSH...
MINNEAPOLIS and DÜSSELDORF, Germany, Sept. 22, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, today announced the opening of its new Customer Experience Center in Düsseldorf, Germany, a flagship facility designed to bring European customers closer to Bio-Techne's latest innovations and scientific expertise.
SYDNEY, Sept. 22, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused biotechnology company developing therapies that selectively reprogram cancer biology, restore anti-tumor immunity and overcome treatment resistance, today announced that Sovargen Co., Ltd., a biotechnology company specializing in central nervous system (CNS) diseases that has exclusively licensed paxalisib from Kazia for the development and...
HYDERABAD, India, Sept. 22, 2026 /PRNewswire/ -- Hyderabad based Deeptech company Hylenr today announced the completion of Phase 1 of an independent validation study of Lattice Confinement Fusion (LCF), conducted at Texas A&M University, marking an important step in the company's efforts to independently evaluate its lattice-based energy technology and advance its roadmap toward commercialization.
TAIPEI, Sept. 22, 2026 /PRNewswire/ -- Merry Life Biomedical today announced the advancement of TML-6, a Taiwan-developed investigational oral therapy for early Alzheimer's disease, into a global Phase 2 study spanning Taiwan, Sweden, and the United States.The study brings together 20 clinical sites, including nine medical centers in Taiwan, seven sites in Sweden, and four centers in the United States. It will evaluate TML-6 in approximately...
Kids with chronic pain conditions are struggling to have their symptoms taken seriously, a study has found, despite impacting most aspects of their lives.
A national campaign is seeking to destigmatise and raise awareness of a physical and neurodevelopmental condition caused by prenatal alcohol exposure.
Experts hope a fresh development in the battle against motor neurone disease will become a national priority, as a state helps researchers develop better care.
Paul Wade says it's scary knowing his memory is going and he is experiencing mood swings due to the repeated head knocks he copped during his soccer career.
Australian scientists have achieved the first pregnancies using a trail-blazing 3D-printed IVF device smaller than the width of a human hair.
A conference has discussed multi-pronged responses to curtailing a debilitating mosquito-borne disease after an outbreak of over 20,000 cases.
A renowned pathologist and former Australian of the Year has been remembered as a selfless fighter who strived to improve the lives of others.
The death of AFL great Neale Daniher from motor neurone disease and NRL player Jai Arrow's diagnosis have thrust the cruel condition back into the spotlight.
Voluntary assisted dying laws in Australia are largely working as intended, but issues around remote access and obstruction by health facilities remain.
Australia may be a nation of walkers rather than runners, as a national study finds adults complete less strenuous exercise than many would expect.
An analysis has found no evidence medicinal cannabis is effective for treating many illnesses but advocates say more data is needed to make a definitive call.
Tax changes, more grants, and targeted training are among the recommendations of a sweeping review of Australia's research and development industry.
Hearing device manufacturer Cochlear has suffered a 19 per cent sell-off after posting weaker-than-expected half-year earnings and trimming its guidance.
Tasked with identifying common medical conditions and recommending treatment, artificial intelligence can deliver deadly advice.
A world-first concussion and head impact study will assess the efficacy of a specially designed headgear during elite and community AFL and rugby games.
Australian scientists have developed a diagnostic device that uses a patient's blood to analyse how deadly brain tumours are responding to medical treatment.
Olympic legend Cathy Freeman is one of 10 people to receive the top honour at the annual Order of Australia awards.
Queensland leads the nation in expanding access to Attention Deficit Hyperactivity Disorder treatment, but doctors are struggling to keep up with demand.
company information
contract
economy, business and finance
health
joint venture
licensing agreement
medical research
